| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/22/1992 | EP0481536A1 Synthetic genes for human interleukin-1-alpha |
| 04/22/1992 | EP0481502A2 Process for the production of chimaeric antibodies |
| 04/22/1992 | EP0481311A2 Aminoacid derivatives |
| 04/22/1992 | EP0481074A1 Packing of column for fractionating and assaying high specific gravity lipoprotein and/or hdl cholesterol |
| 04/22/1992 | EP0481072A1 Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines |
| 04/22/1992 | EP0481070A1 Multimeric gelsolin fusion constructs |
| 04/22/1992 | EP0481000A1 Receptors for fibroblast growth factors |
| 04/22/1992 | EP0480923A1 Method of producing proteins with fviii activity and/or fviii derivatives. |
| 04/22/1992 | EP0480918A1 Reduced size lhrh analogs |
| 04/22/1992 | EP0472599A4 Methods and systems for determining the presence of a pneumocystis carinii antigen in blood |
| 04/22/1992 | EP0317573B1 Antipyretic and anti-inflammatory peptides |
| 04/22/1992 | EP0245291B1 Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody |
| 04/22/1992 | EP0222874B1 A single vial technique for radiolabeling protein |
| 04/22/1992 | CN1060499A Human zona pellucida protein zp3 |
| 04/22/1992 | CN1060498A Recombinant expression vectors capable of expressing immunogenic malarial antigens on surface of salmonella vaccine strains |
| 04/22/1992 | CN1060474A Inhibitors for formation of tumor necrosis factor' processes for preparation thereof and use thereof |
| 04/22/1992 | CN1060473A Fungicidally active compounds |
| 04/22/1992 | CN1016315B Process for preparing hepatitis b antigenic compositions |
| 04/21/1992 | USRE33897 Synthetic polypeptides and antibodies related to Epstein-Barr virus nuclear antigen |
| 04/21/1992 | US5106965 Detection of human adenovirus |
| 04/21/1992 | US5106956 Anticarcinogenic agents |
| 04/21/1992 | US5106955 Process for preparation of antibody conjugates |
| 04/21/1992 | US5106954 Erythropoietin (epo) peptides |
| 04/21/1992 | US5106951 Antineoplastic anthracyline agents intercalated with two aromatic side chains or an oligopeptide and covalently attached to an antibody |
| 04/21/1992 | US5106949 Collagen compositions and methods for preparation thereof |
| 04/21/1992 | US5106834 Hypotensive agents |
| 04/21/1992 | US5106833 Coagulation inhibitors |
| 04/21/1992 | US5106762 Ligand-label conjugates which contain polyoxoanions of sulfur or phosphorus |
| 04/21/1992 | US5106748 Isolated DNA molecule with sequence encoding bone morphogenic protein which induces formation of cartilage and/or bone |
| 04/21/1992 | US5106746 Process for the in vitro immunization of human splenocytes against tumor associated antigens |
| 04/21/1992 | US5106745 Broad spectrum virus inhibitor, UTI-β |
| 04/21/1992 | US5106735 Cloning of a dna sequence encoding a sarcophaga peregrina antibacterial polypeptide precursor |
| 04/21/1992 | US5106733 Bovine granulocyte-macrophage colony stimulating factor |
| 04/21/1992 | US5106731 Kaposi's sarcoma endothelial cells and growth factor |
| 04/21/1992 | US5106726 Synthetic peptides specific for the detection of antibodies to HCV |
| 04/21/1992 | US5106626 Proteins isolated from bones |
| 04/21/1992 | US5106620 Use of a Bacillus thuringiensis microbe for controlling lesser mealworm, Alphitobius diaperinus |
| 04/21/1992 | US5106617 Method of treating immature birds with IL-2 |
| 04/21/1992 | CA1299126C Hirudin-pa and its derivatives |
| 04/21/1992 | CA1299121C Infectious bovine rhinotracheitis virus mutants, vaccines containingsame, methods for the production of same and methods for the use of same |
| 04/21/1992 | CA1299120C Stable dna constructs for expression of alpha-1-antitrypsin |
| 04/21/1992 | CA1299119C Dna encoding a grf precursor |
| 04/21/1992 | CA1299118C Deoxyribonucleic acid segment from a virus |
| 04/21/1992 | CA1299104C Blood cell separation |
| 04/21/1992 | CA1299073C Nucleotide sequence composition and method for detection of neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for genetically distinct group |
| 04/19/1992 | WO1992007003A1 MODIFIED α2-MACROGLOBULINS AND THEIR USE AS SCAVENGERS FOR CYTOKINES AND GROWTH FACTORS |
| 04/19/1992 | WO1992006997A1 Peptide with activity of inhibiting phospholipase a2 originating in inflamed part |
| 04/19/1992 | WO1992006995A1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 04/19/1992 | CA2091771A1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 04/19/1992 | CA2071910A1 Peptide inhibitors of phospholipase a2 purified from inflammatory sites |
| 04/19/1992 | CA2070682A1 Modified.alpha.2-macroglobulins and their use as scavengers for cytokines and growth factors |
| 04/19/1992 | CA2053573A1 Amino acid derivatives |
| 04/18/1992 | WO1992006999A1 Therapeutic fragments of von willebrand factor |
| 04/18/1992 | CA2094259A1 Therapeutic fragments of von willebrand factor |
| 04/18/1992 | CA2053650A1 Endothelin precursors, genes and receptors |
| 04/17/1992 | WO1992007094A1 Cytokine-induced marker for inflammatory response |
| 04/17/1992 | CA2094134A1 Cytokine-induced marker for inflammatory response |
| 04/16/1992 | WO1992006220A1 Detection and isolation of ligands |
| 04/16/1992 | WO1992006212A1 Enhanced expression of viral proteins in drosophila cells |
| 04/16/1992 | WO1992006206A1 Dna, dna constructs, cells and plants derived therefrom |
| 04/16/1992 | WO1992006203A1 MUTANTS OF tPA WHICH ARE RESISTANT TO THEIR COGNATE SERPIN INHIBITOR |
| 04/16/1992 | WO1992006196A1 Gro genes, proteins, and uses thereof |
| 04/16/1992 | WO1992006195A1 Dna and amino acid sequence specific for natural killer cells and t cells |
| 04/16/1992 | WO1992006194A1 Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
| 04/16/1992 | WO1992006193A1 Antibodies directed against cd3 |
| 04/16/1992 | WO1992006191A1 Proteinaceous anti-dental plaque agents |
| 04/16/1992 | WO1992006190A1 Transgenic model for selective targeting of gene products with a megakaryocyte promoter |
| 04/16/1992 | WO1992006117A1 Inhibiting unwanted immune responses |
| 04/16/1992 | WO1992006114A1 Polypeptides derived from interleukin-1 beta, method for the preparation and utilisation thereof, particularly for osteoarticular pathologies |
| 04/16/1992 | WO1992006112A1 Activated ctap and analogs thereof and their use |
| 04/16/1992 | WO1992006111A1 Aprotinin analogues |
| 04/16/1992 | WO1992006109A1 Macrophage status modulation employing synthetic compounds |
| 04/16/1992 | WO1992006106A1 A plant protein useful for treating tumors and hiv infection |
| 04/16/1992 | WO1992006105A1 Antibodies and methods for diagnosis and treatment of diabetes |
| 04/16/1992 | WO1992006104A1 Adipocyte-specific dna sequences and use for the production of transgenic animals exhibiting altered fat metabolism |
| 04/16/1992 | WO1992005800A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 04/16/1992 | WO1992005798A1 Acellular vaccine |
| 04/16/1992 | WO1992005796A1 Peptide inhibitors of neutrophil activation proteins |
| 04/16/1992 | WO1992005794A1 Method for producing th-independent cytotoxic t lymphocytes |
| 04/16/1992 | WO1992005793A1 Targeted immunostimulation with bispecific reagents |
| 04/16/1992 | WO1992002240A3 Novel methods and compositions for treatment of angiogenic diseases |
| 04/16/1992 | WO1991018618A3 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
| 04/16/1992 | DE4032271A1 New cyclo:peptide(s) are atrial natriuretic factor agonists - useful as hypotensives, vasodilators, spasmolytics and broncholytics, and as ligands in receptor binding assays |
| 04/16/1992 | DE4032269A1 New cyclo:peptide(s) are atrial natriuretic factor agonists - useful as hypotensives, vasodilators, spasmolytics and broncholytics, as ligands in receptor binding assays and for purificn. of antibodies |
| 04/16/1992 | DE4032268A1 New cyclo-peptide(s) are atrial natriuretic factor agonists - useful as hypotensives, vasodilators, spasmolytics and broncholytics, as ligands in receptor binding tests and for antibody purification |
| 04/16/1992 | DE4032127A1 Verwendung von disulfidverbrueckten proteinen und peptiden Use of disulfide bonded proteins and peptides |
| 04/16/1992 | CA2093800A1 Plant protein useful for treating tumors and hiv infection |
| 04/16/1992 | CA2092924A1 Gro genes, proteins, and uses thereof |
| 04/16/1992 | CA2092548A1 Method for producing th-independent cytotoxic t lymphocytes |
| 04/16/1992 | CA2052928A1 Genes encoding the human fk-506 binding protein and a.s. cerevisiae homolog, fkb1 and their expression |
| 04/15/1992 | EP0480901A1 Azido-substituted fatty acid analog enzyme substrates |
| 04/15/1992 | EP0480762A2 Novel bacillus thuringiensis isolates active against dipteran pests |
| 04/15/1992 | EP0480651A1 Protein for inhibiting collagenstimulated platelet aggregation |
| 04/15/1992 | EP0480525A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
| 04/15/1992 | EP0480480A2 Enhanced yeast transcription employing hybrid promoter region constructs |
| 04/15/1992 | EP0480389A1 Inhibitors for forming tumor necrosis factor, process for their production and their use |
| 04/15/1992 | EP0480381A1 Endothelin receptors |
| 04/15/1992 | EP0480310A2 Virus-resistant tomato plants |
| 04/15/1992 | EP0480236A2 Resistance gene |
| 04/15/1992 | EP0480041A1 Fused antigen polypeptide |